A new, multi-drug approach to treatment could make many cancers manageable, if not curable, illnesses by overcoming resistance to certain drug treatments, a new study suggests. The findings suggest that, of the billions of cancer cells that exist in a patient, only a tiny percentage — about one in a million — are resistant to drugs used in targeted therapy.